Clinical Research Directory
Browse clinical research sites, groups, and studies.
CAlgary SAlt for POTS
Sponsor: University of Calgary
Summary
Many patients with postural orthostatic tachycardia syndrome (POTS) have decreased plasma volume. Current POTS guidelines recommend \~10 g of salt and 2-3 L of fluid per day. Despite this recommendation, there is no long term data evaluating the use of salt in POTS. This randomized, placebo-controlled cross-over trial will evaluate a high salt diet, compared to a normal salt diet over a period of 3 months. Participants will complete 3 in lab evaluations including autonomic function testing, tilt table testing, blood volume and urine sodium evaluation, plasma catecholamine measurements and and cytokine measurements.
Official title: CAlgary SAlt for Postural Orthostatic Tachycardia Syndrome Study
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-05-07
Completion Date
2028-12-31
Last Updated
2024-05-10
Healthy Volunteers
No
Interventions
Sodium Chloride Capsules
Table salt in slow release capsules.
Microcystalline Cellulose Capsules
Microcrystalline Cellulose Capsules (Placebo)
Locations (1)
University of Calgary
Calgary, Alberta, Canada